Investors Asset Management of Georgia’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
TIA
MJRIC
Investors Asset Management of Georgia's BBH Position: Q1 2023 in Review
Investors Asset Management of Georgia sold out of VanEck Biotech ETF (BBH) in Q1 2023, closing a stake of 2,400 shares — an estimated $383K sold.
Investors Asset Management of Georgia first reported a position in BBH in Q4 2014 and held it in 33 quarters. The position peaked at $748K in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2023.
- Investors Asset Management of Georgia reported no remaining VanEck Biotech ETF position as of Q1 2023 after selling out during the quarter.
- Investors Asset Management of Georgia sold 2,400 VanEck Biotech ETF shares in Q1 2023, an estimated $383K.
- Investors Asset Management of Georgia first reported a position in VanEck Biotech ETF in Q4 2014 and held it in 33 quarters.
- Investors Asset Management of Georgia's VanEck Biotech ETF position peaked at $748K in Q3 2021.
- 115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2023.
Based on Investors Asset Management of Georgia's 13F filing for Q1 2023, filed 1 May 2023.